Cargando…
The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
BACKGROUND: Countries around the world seek innovative ways of closing their remaining gaps towards the target of 95% of people living with HIV (PLHIV) knowing their status by 2030. Offering kits allowing HIV self-testing (HIVST) in private might help close these gaps. METHODS: We analysed the cost,...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287621/ https://www.ncbi.nlm.nih.gov/pubmed/34275873 http://dx.doi.org/10.1136/bmjgh-2021-005019 |
_version_ | 1783723944373649408 |
---|---|
author | Matsimela, Katleho Sande, Linda Alinafe Mostert, Cyprian Majam, Mohammed Phiri, Jane Zishiri, Vincent Madondo, Celeste Khama, Stephen Chidarikire, Thato d'Elbée, Marc Hatzold, Karin Johnson, Cheryl Terris-Prestholt, Fern Meyer-Rath, Gesine |
author_facet | Matsimela, Katleho Sande, Linda Alinafe Mostert, Cyprian Majam, Mohammed Phiri, Jane Zishiri, Vincent Madondo, Celeste Khama, Stephen Chidarikire, Thato d'Elbée, Marc Hatzold, Karin Johnson, Cheryl Terris-Prestholt, Fern Meyer-Rath, Gesine |
author_sort | Matsimela, Katleho |
collection | PubMed |
description | BACKGROUND: Countries around the world seek innovative ways of closing their remaining gaps towards the target of 95% of people living with HIV (PLHIV) knowing their status by 2030. Offering kits allowing HIV self-testing (HIVST) in private might help close these gaps. METHODS: We analysed the cost, use and linkage to onward care of 11 HIVST kit distribution models alongside the Self-Testing AfRica Initiative’s distribution of 2.2 million HIVST kits in South Africa in 2018/2019. Outcomes were based on telephonic surveys of 4% of recipients; costs on a combination of micro-costing, time-and-motion and expenditure analysis. Costs were calculated from the provider perspective in 2019 US$, as incremental costs in integrated and full costs in standalone models. RESULTS: HIV positivity among kit recipients was 4%–23%, with most models achieving 5%–6%. Linkage to confirmatory testing and antiretroviral therapy (ART) initiation for those screening positive was 19%–78% and 2%–72% across models. Average costs per HIVST kit distributed varied between $4.87 (sex worker model) and $18.07 (mobile integration model), with differences largely driven by kit volumes. HIVST kit costs (at $2.88 per kit) and personnel costs were the largest cost items throughout. Average costs per outcome increased along the care cascade, with the sex worker network model being the most cost-effective model across metrics used (cost per kit distributed/recipient screening positive/confirmed positive/initiating ART). Cost per person confirmed positive for HIVST was higher than standard HIV testing. CONCLUSION: HIV self-test distribution models in South Africa varied widely along four characteristics: distribution volume, HIV positivity, linkage to care and cost. Volume was highest in models that targeted public spaces with high footfall (flexible community, fixed point and transport hub distribution), followed by workplace models. Transport hub, workplace and sex worker models distributed kits in the least costly way. Distribution via index cases at facility as well as sex worker network distribution identified the highest number of PLHIV at lowest cost. |
format | Online Article Text |
id | pubmed-8287621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-82876212021-07-30 The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa Matsimela, Katleho Sande, Linda Alinafe Mostert, Cyprian Majam, Mohammed Phiri, Jane Zishiri, Vincent Madondo, Celeste Khama, Stephen Chidarikire, Thato d'Elbée, Marc Hatzold, Karin Johnson, Cheryl Terris-Prestholt, Fern Meyer-Rath, Gesine BMJ Glob Health Original Research BACKGROUND: Countries around the world seek innovative ways of closing their remaining gaps towards the target of 95% of people living with HIV (PLHIV) knowing their status by 2030. Offering kits allowing HIV self-testing (HIVST) in private might help close these gaps. METHODS: We analysed the cost, use and linkage to onward care of 11 HIVST kit distribution models alongside the Self-Testing AfRica Initiative’s distribution of 2.2 million HIVST kits in South Africa in 2018/2019. Outcomes were based on telephonic surveys of 4% of recipients; costs on a combination of micro-costing, time-and-motion and expenditure analysis. Costs were calculated from the provider perspective in 2019 US$, as incremental costs in integrated and full costs in standalone models. RESULTS: HIV positivity among kit recipients was 4%–23%, with most models achieving 5%–6%. Linkage to confirmatory testing and antiretroviral therapy (ART) initiation for those screening positive was 19%–78% and 2%–72% across models. Average costs per HIVST kit distributed varied between $4.87 (sex worker model) and $18.07 (mobile integration model), with differences largely driven by kit volumes. HIVST kit costs (at $2.88 per kit) and personnel costs were the largest cost items throughout. Average costs per outcome increased along the care cascade, with the sex worker network model being the most cost-effective model across metrics used (cost per kit distributed/recipient screening positive/confirmed positive/initiating ART). Cost per person confirmed positive for HIVST was higher than standard HIV testing. CONCLUSION: HIV self-test distribution models in South Africa varied widely along four characteristics: distribution volume, HIV positivity, linkage to care and cost. Volume was highest in models that targeted public spaces with high footfall (flexible community, fixed point and transport hub distribution), followed by workplace models. Transport hub, workplace and sex worker models distributed kits in the least costly way. Distribution via index cases at facility as well as sex worker network distribution identified the highest number of PLHIV at lowest cost. BMJ Publishing Group 2021-07-13 /pmc/articles/PMC8287621/ /pubmed/34275873 http://dx.doi.org/10.1136/bmjgh-2021-005019 Text en © World Health Organization 2021. Licensee BMJ. https://creativecommons.org/licenses/by-nc/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (CC BY NC 3.0 IGO (https://creativecommons.org/licenses/by-nc/3.0/igo/) ), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL. Disclaimer: The author is a staff member of the World Health Organization. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the views, decisions or policies of the World Health Organization. |
spellingShingle | Original Research Matsimela, Katleho Sande, Linda Alinafe Mostert, Cyprian Majam, Mohammed Phiri, Jane Zishiri, Vincent Madondo, Celeste Khama, Stephen Chidarikire, Thato d'Elbée, Marc Hatzold, Karin Johnson, Cheryl Terris-Prestholt, Fern Meyer-Rath, Gesine The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa |
title | The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa |
title_full | The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa |
title_fullStr | The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa |
title_full_unstemmed | The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa |
title_short | The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa |
title_sort | cost and intermediary cost-effectiveness of oral hiv self-test kit distribution across 11 distribution models in south africa |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287621/ https://www.ncbi.nlm.nih.gov/pubmed/34275873 http://dx.doi.org/10.1136/bmjgh-2021-005019 |
work_keys_str_mv | AT matsimelakatleho thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT sandelindaalinafe thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT mostertcyprian thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT majammohammed thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT phirijane thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT zishirivincent thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT madondoceleste thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT khamastephen thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT chidarikirethato thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT delbeemarc thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT hatzoldkarin thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT johnsoncheryl thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT terrisprestholtfern thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT meyerrathgesine thecostandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT matsimelakatleho costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT sandelindaalinafe costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT mostertcyprian costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT majammohammed costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT phirijane costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT zishirivincent costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT madondoceleste costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT khamastephen costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT chidarikirethato costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT delbeemarc costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT hatzoldkarin costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT johnsoncheryl costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT terrisprestholtfern costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica AT meyerrathgesine costandintermediarycosteffectivenessoforalhivselftestkitdistributionacross11distributionmodelsinsouthafrica |